A Food and Drug Administration review found the vaccine prevented severe illness that results in hospitalizations and deaths in a large clinical trial, paving the way for likely authorization this week. If authorized, it would become the third coronavirus vaccine in the United States, which in recent days marked the grim milestone of 500,000 covid-19 deaths. |
No comments:
Post a Comment